Attractive performance
Over the last five years, HBM Healthcare Investments’ net asset value (NAV) per share and share price (HBMN) have demonstrated an attractive performance. Over the same period, the average dividend yield was about 5 percent per year.
Share
Net Asset Value (NAV)
| Net Asset Value (NAV) per share (in CHF) | |
|---|---|
| as at 31 July 2020 | 235.14* |
| as at 15 July 2020 | 241.48 |
| as at 30 June 2020 | 240.72 |
* The expected positive impact from the IPO of Cathay Biotech on the net asset value per HBM share (NAV) has not yet been reflected. Based on the issue price, after deduction of the lock-up discount and the tax provision, the NAV would increase by CHF 23.50 (+10.0%). The first trading day of Cathay’s shares is set for 12 August 2020.